Document Type

Literature Review

Publication Date

Fall 8-15-2024

Reviewing Professor

Dr. Robert Speth

College Course

Drugs of Abuse

Abstract

N, N-Dimethyltryptamine (DMT) is a potent indolethylamine hallucinogen classified as a Schedule I substance, indicating a high potential for abuse and no accepted medical use. Despite this, DMT's unique pharmacological profile, characterized by its interaction with serotonin receptors, particularly 5-HT2A, and its ability to induce profound alterations in perception, emotion, and cognition, has spurred interest in its potential therapeutic applications. This paper explores DMT's mechanisms of action, its psychological and physiological effects, and the risks and side effects associated with its use. While DMT can cause vivid hallucinations, emotional responses ranging from euphoria to existential dread, and various physiological changes, it is generally considered to have a low toxicity profile. However, improper use can lead to severe adverse effects, including serotonin syndrome. Emerging research suggests that DMT may hold promise in treating conditions such as treatment-resistant depression, anxiety disorders, and addiction, owing to its impact on neuroplasticity and the default mode network. The paper also examines the legal and safety challenges surrounding DMT, advocating for a balanced approach to its study and application. Rigorous clinical trials and thoughtful regulation are necessary to explore DMT's potential benefits while minimizing its risks, positioning it at the intersection of a drug of abuse and a promising therapeutic agent.

Download

Share

COinS